02.06.15
West Chester, Ohio-based AtriCure Inc. has instated Douglas Seith in the role of chief operating officer. Seith will now be responsible for all global commercial organizations as well as education and clinical science programs. The firm, which makes surgical treatments for atrial fibrillation and left atrial appendage management, also has promoted Andy Wade to senior vice president and chief financial officer.
“Doug is an exceptional executive who has strong customer skills as well as keen clinical and technical capabilities,” Mike Carrel, president and CEO of AtriCure, said in prepared remarks. “In his decade plus tenure at AtriCure, he has helped lead the company’s growth. His leadership has been paramount to our success and I have confidence that his innovative thinking and vision will continue to enhance the strategic direction and growth of the company.”
“Andy has served as our vice president and chief financial officer since 2013, and possesses a particularly impressive track record over the course of his seven years at AtriCure,” Carrel added about Wade. “Some of his many accomplishments include leading two public financings in the span of 13 months, raising over $125 million in the process, while supporting our growth and the integration of Estech. It is because of these and many important contributions as well as his leadership strengths that Andy has been promoted to senior vice president.”
“Doug is an exceptional executive who has strong customer skills as well as keen clinical and technical capabilities,” Mike Carrel, president and CEO of AtriCure, said in prepared remarks. “In his decade plus tenure at AtriCure, he has helped lead the company’s growth. His leadership has been paramount to our success and I have confidence that his innovative thinking and vision will continue to enhance the strategic direction and growth of the company.”
“Andy has served as our vice president and chief financial officer since 2013, and possesses a particularly impressive track record over the course of his seven years at AtriCure,” Carrel added about Wade. “Some of his many accomplishments include leading two public financings in the span of 13 months, raising over $125 million in the process, while supporting our growth and the integration of Estech. It is because of these and many important contributions as well as his leadership strengths that Andy has been promoted to senior vice president.”